Medicxi launches $300m European late-stage life sciences fund backed by Google company

Verily joins Novartis and the European Investment Fund Venture capital group Medicxi has announced a $300m late-stage life sciences fund that is backed by Novartis, the European Investment Fund (EIF) and Verily Life Sciences, the healthcare division of Google's holding company Alphabet.…